EN

Announcements & Notices

All 2024 2023 2022 2021
Total:61 items
Total: 61 items
All Announcements and Notices Monthly Returns
All
  • 16
    2023-10
    Announcements and Notices
    VOLUNTARY ANNOUNCEMENT - IMPORTANT CLINICAL RESEARCH RESULTS OF ABSK011 AND ABSK043 WILL PRESENT AT THE ESMO CONFERENCE
  • 16
    2023-10
    Announcements and Notices
    VOLUNTARY ANNOUNCEMENT - PRECLINICAL STUDY RESULTS OF PRMT5*MTA AND PD-L1 PRESENT AT ENA
  • 09
    2023-10
    Monthly Returns
    Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2023
  • 26
    2023-09
    Announcements and Notices
    VOLUNTARY ANNOUNCEMENT - ABSK011 HCC COMBO CLINICAL TRIAL APPROVED BY NMPA
  • 25
    2023-09
    Announcements and Notices
    VOLUNTARY ANNOUNCEMENT - ABSK011 HCC CLINICAL TRIAL APPROVED BY U.S. FDA
  • 18
    2023-09
    2023 INTERIM REPORT
  • 11
    2023-09
    Announcements and Notices
    VOLUNTARY ANNOUNCEMENT - ABSK021 PHASE III TGCT CLINICAL TRIAL APPROVED BY EMA
  • 06
    2023-09
    Monthly Returns
    Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2023
  • 29
    2023-08
    Announcements and Notices
    VOLUNTARY ANNOUNCEMENT - THE SHAREHOLDING OF THE FOUNDERS OF THE COMPANY
  • 15
    2023-08
    Announcements and Notices
    INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2023
Go to Page
Supplied by:Realxen.net
Terms of Service | Cookie Policy | Privacy Policy

Tel:(+86) 021-68912098

E-Mail:Public@abbisko.com Bd@abbisko.com IR@abbisko.com

Copyright © 2021 All rights reserved:Abbisko Therapeautics     沪ICP备17056565号   

Lang
En
繁
简